These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 11226142)

  • 1. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
    Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
    Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
    González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
    Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
    Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice.
    Hamdy MM; Mamiya T; Noda Y; Sayed M; Assi AA; Gomaa A; Yamada K; Nabeshima T
    Behav Brain Res; 2001 Jan; 118(1):85-93. PubMed ID: 11163637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
    Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
    Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
    Mamiya T; Matsumura T; Ukai M
    Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
    Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the development of morphine dependence/tolerance by nefiracetam: involvement of adenosine 3':5'-cyclic monophosphate system.
    Itoh A; Shiotani T; Nakayama S; Mamiya T; Hasegawa T; Noda Y; Nabeshima T
    Behav Brain Res; 2000 Oct; 115(1):65-74. PubMed ID: 10996409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
    Thompson BE; Sachs BD; Kantak KM; Cherry JA
    Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
    Nagakura A; Niimura M; Takeo S
    Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
    Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
    J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
    Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
    J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
    Singh P; Sharma B; Gupta S; Sharma BM
    Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G; Laorden ML; Milanés MV
    Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
    Harada D; Tsukumo Y; Takashima Y; Manabe H
    Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.